Organon Investor Relations Material
Latest events
Q2 2024
Organon
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Organon & Co
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe and Canada
U.S.
Asia Pacific and Japan
China
Other
Expenses by
Financials
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. The company operates under the Organon & Co. Pharmaceuticals and Organon brands. Its products include hormone contraceptives; biosimilars; women's health products consisting of fertility, menopause, contraception, osteoporosis and gynecological cancer; and treatments for psychiatric and neurological disorders comprising schizophrenia, bipolar mania disorder and depression. The company also offers food animal health products, including pain relief for horses, cattle and sheep; and anti-infectives for poultry.
Key slides for Organon & Co
Q2 2024
Organon & Co
Q1 2024
Organon & Co
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
OGN
Country
🇺🇸 United States